Inactive Instrument

Response Biomedical Corp Stock

Equities

Duration

Period

Style

Response Biomedical Corp. : Completes Going-Private Transaction	16-11-29	MW
Response Biomedical : Announces Third Quarter Results	16-11-14	PU
Response Biomedical Corp. : Announces Third Quarter 2016 Financial Results and Update on Going-Private Transaction	16-11-10	MW
Response Biomedical Corp. : Receives Court Approval of Going-Private Transaction	16-09-19	MW
Response Biomedical Corp. : Receives Shareholder Approval of Going-Private Transaction	16-09-16	MW

Managers	Title	Age	Since
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-
Anastasios Tsonis DFI	Director of Finance/CFO	44	10-12-31
Eric Whitters COO	Chief Operating Officer	-	-

Members of the board	Title	Age	Since
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-

Sector

	1st Jan change	Capi.
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B